These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7047843)
1. [Insulin receptors and interference by medication: in vivo and in vitro studies]. Canivet B; Dolais-Kitabgi J; Freychet P Journ Annu Diabetol Hotel Dieu; 1982; ():61-70. PubMed ID: 7047843 [No Abstract] [Full Text] [Related]
5. [Insulin receptor and postreceptor disorders: significance for the development and therapy of carbohydrate metabolic disorders]. Schernthaner G; Prager R Acta Med Austriaca; 1984; 11(3-4):70-8. PubMed ID: 6382903 [TBL] [Abstract][Full Text] [Related]
6. [Insulin resistance in type 2 diabetes. Receptor and post-receptor aspects]. Purrello F; Trischitta V; Vigneri R Minerva Endocrinol; 1984; 9(2):221-8. PubMed ID: 6390135 [No Abstract] [Full Text] [Related]
7. [Biguanides in the treatment of obesity]. Giulietti M Clin Ter; 1978 Jan; 84(1):99-100. PubMed ID: 415837 [No Abstract] [Full Text] [Related]
8. A clinical study on insulin receptors of mononuclear cells in diabetes. Dalimunthe D Hiroshima J Med Sci; 1980 Dec; 29(4):203-18. PubMed ID: 7009506 [No Abstract] [Full Text] [Related]
10. [Diabetes mellitus and obesity: monotherapy using biguanides]. Bäbler M Schweiz Med Wochenschr; 1973 Apr; 103(17):641-5. PubMed ID: 4704806 [No Abstract] [Full Text] [Related]
11. Insulin binding to erythrocytes in diabetes mellitus. Okada Y; Arima T; Okazaki S; Nakata K; Yamabuki T; Nagashima H Acta Med Okayama; 1981 Oct; 35(4):273-7. PubMed ID: 6457514 [TBL] [Abstract][Full Text] [Related]
12. [Effect of peroral blood glucose reducing therapy on insulin receptor interactions in patients with type II diabetes mellitus]. Balabolkin MI; Nedosugova LV; Gavriliuk LM; Gincherman LE Ter Arkh; 1983; 55(9):136-40. PubMed ID: 6356436 [No Abstract] [Full Text] [Related]
13. [Insulin cell receptors in diabetes caused by pancreatitis]. Frati-Munari AC; Rodríguez-Rodríguez J; Altamirano P Arch Invest Med (Mex); 1987; 18(2):157-66. PubMed ID: 3310946 [No Abstract] [Full Text] [Related]
14. Pharmacological principles of treatment in diabetes. Larkins RG Med J Aust; 1985 Jan; 142(2):117-20. PubMed ID: 3880864 [TBL] [Abstract][Full Text] [Related]
15. [Prospective studies on the prevention of manifestations of protodiabetes using sulfonylurea compounds and biguanides]. Adolph W; Panzram G; Ruttmann B Z Gesamte Inn Med; 1976 Jan; 31(1):1-6. PubMed ID: 969760 [No Abstract] [Full Text] [Related]
16. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
17. Erythrocyte insulin receptors in non-insulin-dependent diabetics before and after treatment. Tanggo Y Hiroshima J Med Sci; 1985 Sep; 34(3):331-45. PubMed ID: 3905718 [No Abstract] [Full Text] [Related]
18. [Clinical applications of insulin receptor on red cells]. De Pirro R; Lauro R; Camagna A Journ Annu Diabetol Hotel Dieu; 1982; ():35-43. PubMed ID: 7098255 [No Abstract] [Full Text] [Related]